コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 CRF (30 ng) facilitated strategy set-shifting performanc
2 CRF constricts the small bowel and increases fructose ma
3 CRF dose-dependently impaired working memory performance
4 CRF injection caused a significant increase in salivary
5 CRF is strongly, inversely, and independently associated
6 CRF is the first endogenous neuropeptide that can be sho
7 CRF mediates numerous stress-related endocrine, autonomi
8 CRF-enriched CEA-DA projections are positioned to influe
9 CRF-producing neurons and CRF in the CeA are required fo
10 a corticotropin-releasing factor receptor 1 (CRF-R1)-dependent mechanism, and that these CRF1 and NE
12 ed nucleus vs central nucleus divisions; (2) CRF content of the CEA-DA path; and (3) striatal subregi
13 ons at 5-HT2C receptors (5-HT2CRs), engage a CRF(BNST) inhibitory microcircuit that silences anxiolyt
18 min to 135 min was significantly lower after CRF compared with saline [mean difference: 5911 mL . min
20 ith their respective high-affinity agonists, CRF+urocortin2, resulted in approximately twofold increa
22 ons for understanding how discrete amygdalar CRF pathways modulate longer-lasting fear in anxiety- an
23 ficant interaction was found between age and CRF in each trajectory, indicating that CRF was more str
25 le, performed better than traditional CH and CRF parameters in differentiating forme fruste KC from n
31 th Edition, Clinical Modification codes, and CRF profile (hypertension, diabetes mellitus, hyperchole
32 hat corticotropin-releasing factor (CRF) and CRF receptors are prominent in the PFC, the cognitive ef
33 bled generating atomistic models of CRF- and CRF(12-41)-bound CRF1R, further explored by molecular dy
37 tra-VTA antagonism of CRF-R1 in the pVTA and CRF-R2 in the aVTA during each social defeat prevented e
38 (Ucn1) and two receptor subtypes, CRF-R1 and CRF-R2, in primary human articular chondrocytes (AC) and
41 THODS AND Between 1987 and 2014, we assessed CRF in 21 080 HF-free subjects (58.3+/-11 years) at the
42 thcare expenditures with optimal and average CRF profile were $5946 and $3731 less compared with thos
46 knowledge related to the association between CRF and health outcomes, increase awareness of the added
48 s was to investigate the association between CRF and incident AF in a large, multiracial cohort that
50 drinking; 2) inhibiting VTA-projecting BNST CRF neurons attenuates binge-like drinking; and 3) binge
52 ) neurons in the CeA is potently enhanced by CRF and that CRFR1 signaling in the CeA is critical for
56 p009 (CRF-ArchT) to examine the role of CeAL CRF neurons and projections to the BNSTDL during the acq
60 (i) first-order to higher-order linear-chain CRFs, and from (ii) first-order to higher-order semi-Mar
63 ; Marfan syndrome CRF 9.77 +/- 1.65, control CRF 11.03 +/- 1.72, P = .01) and corneas were flatter in
64 ing acute defeat, but, with repeated defeat, CRF is recruited into the anterior VTA (aVTA) and CRF to
67 rminalis and central amygdala, and dopamine, CRF, kappa/dynorphin, and glutamate transmission in othe
68 ic transmission in the CeA, and dysregulated CRF-FAAH facilitates stress-induced increases in glutama
69 udies examined the influence of dysregulated CRF and FAAH systems in altering excitatory transmission
70 y stressed rats continue to express elevated CRF tone within the VTA and antagonism of pVTA CRF-R1 or
71 caine taking, and that persistently elevated CRF tone in the VTA may drive later cocaine seeking thro
73 nsistent with a mechanism whereby the excess CRF that characterizes stress-related diseases initiates
74 hestrates the stress response, and excessive CRF is thought to contribute to the pathophysiology of t
75 on and interaction of heterologous expressed CRF-BP and CRF2alphaR in yeast, human embryonic kidney 2
76 n known that corticotropin-releasing factor (CRF) and CRF receptors are prominent in the PFC, the cog
77 neuropeptide corticotropin releasing factor (CRF) and its receptors (CRF-R1, CRF-R2) are located in t
78 europeptides corticotropin-releasing factor (CRF) and orexin-A in the ventral tegmental area (VTA) pl
80 ion, reduced corticotropin-releasing factor (CRF) immunodensity in the paraventricular nucleus of the
81 g a role for corticotropin-releasing factor (CRF) in the IC during craving and relapse, a subsequent
84 opulation of corticotropin-releasing factor (CRF) neurons in the bed nucleus of the stria terminalis
85 injection of corticotropin-releasing factor (CRF) on fructose malabsorption and the resulting volume
87 by increased corticotropin releasing factor (CRF) receptor-1 expression and signalling, which modulat
89 europeptide, corticotropin-releasing factor (CRF) regulates the dorsal raphe nucleus-serotonin (DRN-5
94 blockade of corticotropin-releasing factor (CRF) type 1 receptors (CRFR1s) reduces stress-induced th
96 tigated how corticotrophin releasing factor (CRF), a critical stress response mediator, influences am
99 municate via corticotropin-releasing factor (CRF), but studies have yet to examine its function in fe
100 volvement of corticotropin-releasing factor (CRF), noradrenaline, dopamine, glutamate, kappa/dynorphi
103 vestigate whether corneal resistance factor (CRF) and central corneal thickness (CCT) differ between
106 steresis (CH) and corneal resistance factor (CRF) were decreased (Marfan syndrome CH 9.45 +/- 1.62, c
107 act of favorable cardiovascular risk factor (CRF) profile on healthcare expenditure and resource util
108 steresis [CH] and corneal resistance factor [CRF]), and corneal wavefront aberrations were assessed b
109 cations [i.e., chromatin regulatory factors (CRF)] and genes encoding histone proteins harbor recurre
111 We show that the CYTOKININ RESPONSE FACTORS (CRFs), transcription factors downstream of cytokinin per
116 nsistent with a role in discriminative fear, CRF neurons undergo plasticity following threat conditio
117 hopeptides that were more abundant in female CRF-OE mice were overrepresented in an Alzheimer's disea
119 tworks (DCNN) and conditional random fields (CRF); it can model not only complex sequence-structure r
120 rary implementing conditional random fields (CRFs), a class of probabilistic graphical models, for ro
121 hat low levels of cardiorespiratory fitness (CRF) are associated with a high risk of cardiovascular d
124 established that cardiorespiratory fitness (CRF) is inversely associated with cardiovascular and all
125 n between LTL and cardiorespiratory fitness (CRF), an enduring trait influenced by chronic habituatio
126 zed, with impairment observed only following CRF infusions into the caudal dorsomedial PFC (dmPFC).
130 e 4 most commonly recommended treatments for CRF-exercise, psychological, combined exercise and psych
133 (33.14%), 20 circulating recombinant forms (CRFs; 11.63%), and 20 unclassified (11.63%) sequences we
139 hese results reveal an essential 5-HT(DRN)-->CRF(BNST) circuit governing fear and anxiety, and provid
140 nosed as having cancer at Medicare age, high CRF in midlife was associated with an adjusted 32% (HR,
141 al, and prostate cancers among men with high CRF were 0.45 (95% CI, 0.29-0.68), 0.56 (95% CI, 0.36-0.
145 actor (CRF) receptors-which bind the hormone CRF as well as related peptides-are important regulators
148 , we show that Abeta species can hyperexcite CRF neurons, providing a mechanism by which Abeta influe
150 0.26; 95% CI, 0.13-0.38; P < .001) improved CRF during and after primary treatment, whereas pharmace
151 exercise training had significantly improved CRF (mL/kg per min; weighted mean difference, 2.72; 95%
152 is study used a phosphoproteomic approach in CRF-overexpressing (CRF-OE) mice to test the proof of pr
153 hift cognitive processing through changes in CRF neurotransmission in the DRN and the association of
156 bitory synaptic transmission specifically in CRF neurons via a previously unknown Gi-mediated, PKA-de
157 udy the role of constitutive upregulation in CRF systems on amygdalar eCB function and persistent anx
158 n this review, we discuss DNA alterations in CRFs and how these influence tumor chromatin structure a
159 ing factor (CRF) family of peptides includes CRF and three urocortins, which signal through two disti
164 ow that excitability of genetically isolated CRF-receptive (CRFR1) neurons in the CeA is potently enh
165 s, CRF1 and CRF2 , and two of their ligands, CRF and urocortin 3, respectively, in African mole-rat s
172 opeptides that distinguished female and male CRF-OE mice were overrepresented in unique pathways that
174 re is an inverse association between midlife CRF and incident lung and colorectal cancer but not pros
175 preciable phenotypes, disruption of multiple CRFs results in larger rosettes, delayed leaf senescence
178 s of the release processes and to design new CRFs in a shorter time and with relatively lower cost.
180 tra-dmPFC administration of the nonselective CRF antagonist, D-Phe-CRF, dose-dependently improved wor
184 se of this statement is that the addition of CRF for risk classification presents health professional
185 diabetes mellitus, but that the addition of CRF to traditional risk factors significantly improves t
192 alamus to DRN-driven serotonergic control of CRF levels in the amygdala may contribute to the transit
193 hift from MRN-driven serotonergic control of CRF levels in the hypothalamus to DRN-driven serotonergi
198 hifting performance, whereas higher doses of CRF and urocortin II that would interact with CRF2 were
199 is unclear whether chronic dysregulation of CRF systems induces maladaptive changes in amygdalar eCB
201 s-induced changes in the cellular effects of CRF in the DRN translate to changes in cognitive effects
203 n nonstressed rats by intra-BLA infusions of CRF (200 ng/0.5 mul), but not by repeated NE infusions (
204 light recent advances in the interactions of CRF receptors with other GPCRs and non-GPCR proteins and
205 ircuitry studies indicate the involvement of CRF and noradrenaline transmission in bed nucleus of str
207 ion, chronic stress did not induce a loss of CRF-induced EPSCs in basal dendrites, thereby creating a
208 inistration in rats.In vivo microdialysis of CRF in the VTA demonstrated that CRF is phasically relea
209 utanol extracts of rhubarb in a rat model of CRF with adenine-induced chronic tubulointerstitial neph
210 data enabled generating atomistic models of CRF- and CRF(12-41)-bound CRF1R, further explored by mol
212 better assess the translational potential of CRF antagonists, we examined the cognitive effects of sy
216 stochemical techniques to assess the role of CRF-CRFR1 signaling in CeA in stress-induced hyperalgesi
218 mized, placebo-controlled crossover study of CRF compared with saline injection in 11 male and 10 fem
219 es, increase awareness of the added value of CRF to improve risk prediction, and suggest future direc
220 etric analysis of release characteristics of CRFs is of paramount importance for the design and devel
223 ements of CH (10.6+/-1.6 mmHg; P = 0.670) or CRF (10.3+/-1.7 mmHg; P = 0.103) between the ethnic grou
225 phoproteomic approach in CRF-overexpressing (CRF-OE) mice to test the proof of principle that when CR
226 ive AD pathogenesis, which directly perturbs CRF signaling, thereby enhancing chronic PTSD symptoms w
227 te neuroadaptive changes in tonic and phasic CRF with repeated stress, that CRF release during stress
228 on of the nonselective CRF antagonist, D-Phe-CRF, dose-dependently improved working memory performanc
229 4.7%) had average, and 2728 (17.4%) had poor CRF profile, translating to 54.2, 64.1, and 24.9 million
231 There is evidence that CRF-BP potentiates CRF and urocortin 1 actions through CRF type 2 receptors
232 l drinking, but inhibition of VTA-projecting CRF neurons from the BNST significantly reduced intake.
233 ticotropin releasing factor binding protein (CRF-BP) was originally recognized as CRF sequestering pr
237 sing factor (CRF) and its receptors (CRF-R1, CRF-R2) are located in the VTA and influence dopaminergi
238 in releasing factor (CRF) and its receptors (CRF-R1, CRF-R2) are located in the VTA and influence dop
239 ike LgA cocaine self-administration, reduced CRF immunodensity in the central nucleus of the amygdala
240 cal interventions are effective for reducing CRF during and after cancer treatment, and they are sign
244 urocortin1 (Ucn1) and two receptor subtypes, CRF-R1 and CRF-R2, in primary human articular chondrocyt
245 CH 11.24 +/- 1.21, P = .01; Marfan syndrome CRF 9.77 +/- 1.65, control CRF 11.03 +/- 1.72, P = .01)
246 d viral-based strategy to selectively target CRF neurons with the optogenetic silencer archaerhodopsi
248 se results are the first to demonstrate that CRF acts in the PFC to regulate PFC-dependent cognition.
249 dialysis of CRF in the VTA demonstrated that CRF is phasically released in the posterior VTA (pVTA) d
251 results were validated by demonstrating that CRF overexpression in females was associated with increa
254 relapse, a subsequent experiment found that CRF receptor-1 (CRF1) blockade in the AId similarly redu
258 and CRF in each trajectory, indicating that CRF was more strongly associated with the aging trajecto
259 clinical evidence demonstrates not only that CRF is a potentially stronger predictor of mortality tha
263 ogous expression of each protein showed that CRF-BP was localized mainly in secretory granules and CR
264 ic and phasic CRF with repeated stress, that CRF release during stress may contribute to later escala
268 Significant changes were found between the CRF and control groups representing characteristic pheno
271 mpared the telencephalic distribution of the CRF receptors, CRF1 and CRF2 , and two of their ligands,
273 apamycin complex 1 synaptogenic pathway; the CRF-induced EPSCs required an intact BLA input and were
275 This effect could only be removed using the CRF-R1 selective antagonist CP-154526, suggesting Ucn1 a
276 to predict the release of nutrients from the CRFs to elucidate fundamental understanding of the dynam
283 9, 12-15, 18, 19, 22-26, 28, 31) had k(i) to CRF receptors in the high picomolar and low nanomole ran
284 eide breath test and the adrenal response to CRF was assessed by serial salivary cortisol measurement
285 opulation of rats 5-HT neuronal responses to CRF have been demonstrated to shift from CRF1-mediated i
286 optogenetic silencer archaerhodopsin tp009 (CRF-ArchT) to examine the role of CeAL CRF neurons and p
287 ion modes may be more effective for treating CRF at different points in the cancer treatment trajecto
289 e self-administration in a 24 h "binge." VTA CRF continues to influence cocaine seeking in stressed a
291 hese acute and persistent changes to the VTA CRF system may lead to better therapeutic interventions
292 of binge-like ethanol consumption on the VTA CRF system were assessed following drinking-in-the-dark
293 at ethanol-induced activation of BNST-to-VTA CRF projections is critical in driving binge-like ethano
294 s of the stria terminalis (BNST) to the VTA, CRF neurons in this circuit were chemogenetically inhibi
297 ice to test the proof of principle that when CRF is in excess, sex-biased CRF1 coupling translates in
298 fe course in adults and to determine whether CRF modifies the age-associated trajectory of lipids and
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。